Solutions
Immunix™
Our ImmunixTM precision medicine platform, which has produced the world’s largest and fastest growing biomarker-clinical dataset for infection in acute care, leverages machine learning algorithms to illuminate the complex biological states of patients more comprehensively.
Sepsis ImmunoScore®
Using ImmunixTM, we created and validated the Sepsis ImmunoScore, the first FDA authorized AI diagnostic for sepsis detection. Leveraging biomarkers, clinical data and AI, the Sepsis ImmunoScore holistically evaluates a patient’s chances of experiencing adverse outcomes within 24 hours.
Sepsis ImmunoScore®
Already Part of your Workflow
Easily integrates into your current clinical workflow and relies on data you already collect. No additional equipment needed.
Collect
Providers collect routine medical history, vitals, demographic data, traditional lab results and new biomarker measurements on patients suspected of having a serious infection that could lead to a deadly immune response.
Analyze
Using 22 parameters, the Sepsis ImmunoScore uses machine learning to rapidly identify and categorize the individual’s biological response to evaluate the risk of the patient having or developing sepsis within the next 24 hours.
Inform
With a direct integration into hospital EMRs, the ImmunixTM platform displays the results of the Sepsis ImmunoScore, including full transparency into how the score was calculated for each individual patient.
